 compared to other treatments. When they compared specific combinations, such as sulfonylureas and insulin, with the newer medications, such as GLT2s and GLP1s, for a side effect of interest, severe hypoglycemia, they found that these newer medications also significantly reduced hypoglycemia. Not unexpected.